2 news items
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
AGIO
14 May 24
factors, risks and uncertainties that may cause actual events or results to differ materially from Agios' current expectations and beliefs. For example
Agios Reports Business Highlights and First Quarter 2024 Financial Results
AGIO
2 May 24
to differ materially from Agios' current expectations and beliefs. For example, there can be no guarantee that any product candidate Agios is developing
- Prev
- 1
- Next